Dolby Laboratories, Inc has 8 Schedule 13D or 13G filings on record since 2026-02-11. 6 holders' latest filing reports 5% or more of class a stock. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Dagmar Dolby | 36% | 34,368,358 | SCHEDULE 13D/A, 2026-02-13 | 2026-02-11 |
| BlackRock, Inc. | 10% | 6,041,219 | SCHEDULE 13G/A, 2026-06-04 | 2026-05-31 |
| Vanguard Portfolio Management | 8.24% | 5,019,900 | SCHEDULE 13G, 2026-04-29 | 2026-03-31 |
| Morgan Stanley | 8.2% | 5,020,777 | SCHEDULE 13G/A, 2026-05-11 | 2026-03-31 |
| Bank of New York Mellon Corp | 7.4% | 4,499,820 | SCHEDULE 13G/A, 2026-04-28 | 2026-03-31 |
| Vanguard Capital Management | 5.24% | 3,193,409 | SCHEDULE 13G, 2026-04-29 | 2026-03-31 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-26 | 2026-03-13 |
Purpose of Transaction (Item 4)
Dagmar Dolby
Item 4 of the Statement is amended by adding the following at the end thereof: There was a decrease in the Reporting Persons' beneficial holdings of more than one percent of the outstanding shares of Class A Common Stock resulting from the gifting of (i) 43,500 shares of Class A Common Stock beneficially owned by the Dagmar Dolby Fund and (ii) 890,000 shares of Class A Common Stock beneficially owned by the Dagmar Dolby Trust (collectively, the "Transfers"), partially offset by 3,140 shares of Class A Common Stock issued to David E. Dolby upon the vesting of restricted stock units. The Transfers were effected solely for charitable gifting purposes, and were transfers for no value without the payment or receipt of any funds or other consideration by the Reporting Persons in exchange therefor.Item 4 of the SCHEDULE 13D/A filed 2026-02-13
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-02-11 | Morgan Stanley | 10.2% | SCHEDULE 13G/A |
| 2026-02-13 | Dagmar Dolby | 36% | SCHEDULE 13D/A |
| 2026-03-26 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-28 | Bank of New York Mellon Corp | 7.4% | SCHEDULE 13G/A |
| 2026-04-29 | Vanguard Capital Management | 5.24% | SCHEDULE 13G |
| 2026-04-29 | Vanguard Portfolio Management | 8.24% | SCHEDULE 13G |
| 2026-05-11 | Morgan Stanley | 8.2% | SCHEDULE 13G/A |
| 2026-06-04 | BlackRock, Inc. | 10% | SCHEDULE 13G/A |
Tools for this story
Each opens in a new tab, filled in for Dolby Laboratories, Inc. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.